Literature DB >> 1580116

The positive pleural effusion. A retrospective study of cytopathologic diagnoses with autopsy confirmation.

L DiBonito1, G Falconieri, I Colautti, D Bonifacio, S Dudine.   

Abstract

We performed an investigation focusing on the distribution of tumor types responsible for positive pleural effusions in 143 patients who died of malignancy and underwent autopsy. The principal malignant tumors were lung carcinoma (41 cases, 51.2%) and pleural mesothelioma (23 cases, 28.7%) in males and breast carcinoma (24 cases, 38.2%) and lung carcinoma (13 cases, 20.6%) in females. Histologically, most of the cases belonged to the adenocarcinoma category. The first morphologic diagnosis was a cytologic one in 86 cases (60.1%), especially regarding lung cancer. In breast cancer a positive pleural effusion always preceded recurrent disease with a rapidly progressive course, even a long time after the initial surgery. The results of this study, based on both cytomorphologic features and postmortem data on the tumor sites, may be a useful working framework for the cytologist dealing with a positive pleural effusion.

Entities:  

Mesh:

Year:  1992        PMID: 1580116

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  9 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 2.  Pleural effusion.

Authors:  A R Medford; A Medford; N Maskell
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

3.  Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.

Authors:  B M Stiles; P S Adusumilli; A Bhargava; S F Stanziale; T H Kim; M-K Chan; R Huq; R Wong; V W Rusch; Y Fong
Journal:  Cancer Gene Ther       Date:  2006-01-01       Impact factor: 5.987

4.  Chemical Pleurodesis Using Mistletoe Extraction (ABNOVAviscum(®) Injection) for Malignant Pleural Effusion.

Authors:  Jeong Su Cho; Kook Joo Na; Yongjik Lee; Yeong Dae Kim; Hyo Yeong Ahn; Chang Ryul Park; Young Chul Kim
Journal:  Ann Thorac Cardiovasc Surg       Date:  2015-12-04       Impact factor: 1.520

Review 5.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Amelia O Clive; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell
Journal:  Cochrane Database Syst Rev       Date:  2016-05-08

6.  Interventions for the management of malignant pleural effusions: a network meta-analysis.

Authors:  Alexandra Dipper; Hayley E Jones; Rahul Bhatnagar; Nancy J Preston; Nick Maskell; Amelia O Clive
Journal:  Cochrane Database Syst Rev       Date:  2020-04-21

7.  Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant and malignant pleural effusions.

Authors:  Dimo Dietrich; Maria Jung; Svenja Puetzer; Annette Leisse; Emily Eva Holmes; Sebastian Meller; Barbara Uhl; Philipp Schatz; Claudia Ivascu; Glen Kristiansen
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

8.  Prognostic Factors of Malignant Pleural Effusion among Palliative Care Outpatients: A Retrospective Study.

Authors:  Jenifer Jeba; Renitha M Cherian; Balamugesh Thangakunam; Reena George; J Visalakshi
Journal:  Indian J Palliat Care       Date:  2018 Apr-Jun

9.  Effect of chest tube size on pleurodesis efficacy in malignant pleural effusion: a meta-analysis of randomized controlled trials.

Authors:  Inderpal Thethi; Shokufeh Ramirez; Wei Shen; Dingding Zhang; Maha Mohamad; Upendra Kaphle; Fayez Kheir
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.